Investing

The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.

Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.

Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

The investment will accelerate Nexus IT’s U.S. expansion and support acquisitions of culturally aligned MSPs in healthcare and other regulated industries.

The two organizations will collaborate to accelerate the company's growth and enhance proactive care and management of chronic diseases.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.

The company will use the funds to support a 510(k) submission to the FDA for its Flexi-Port SLF-TANL for oncology patients.

The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.